Eptifibatide Acetate ≥ 98% CAS No: 148031-34-9
Eptifibatide Acetate ≥ 98% CAS No: 148031-34-9
Eptifibatide Acetate ≥ 98% CAS No: 148031-34-9,Eptifibatide Acetate ≥ 98% ,Eptifibatide Acetate,Eptifibatide Acetate CAS No: 148031-34-9,CAS No: 148031-34-9
Product Name: Eptifibatide Acetate API Powder
Product Purity: ≥ 98%
CAS No: 148031-34-9
Send Inquiry
Description
Research Grade ≥98%
Eptifibatide Acetate
Selective GPIIb/IIIa Antagonist | High-Purity Cyclic Heptapeptide for Cardiovascular Research
Product Description
Eptifibatide Acetate is a synthetic cyclic heptapeptide that acts as a highly selective and reversible antagonist for the platelet GPIIb/IIIa receptor. Shaanxi Sunrise Pharmaceutical Co., Ltd. provides this premium research reagent with high batch-to-batch consistency, synthesized using advanced solid-phase peptide synthesis (SPPS) and purified to ≥98.0% via HPLC.
As a key tool in cardiovascular pharmacology, it is used to study the mechanisms of platelet aggregation and thrombus formation without the immunogenic risks often associated with biological proteins.
Research Mechanism Reference
Note: The following is for background academic reference only.
GPIIb/IIIa Blocking: Reversibly inhibits the binding of fibrinogen, von Willebrand factor, and other adhesive ligands to GPIIb/IIIa receptors.
Common Pathway Inhibition: Prevents the final common pathway of platelet aggregation, regardless of the activation stimulus (ADP, collagen, or thrombin).
Primary Application Scenarios
Platelet Biology
Investigation of receptor-ligand kinetics and signaling pathways in platelet activation.
Thrombosis Research
In vitro and ex vivo modeling of thrombus growth and stabilization mechanisms.
Cardiovascular Drug Discovery
Acting as a benchmark control for screening novel anti-platelet and anti-thrombotic agents.
Hematology Assays
Reagent for standardizing platelet function tests and receptor binding assays.
Core Advantages
Ultra-High Purity (≥98%)
Low Residual Impurities
Excellent Batch Consistency
Detailed COA Documentation
Cold-chain Global Shipping
Customizable Packaging
B2B Procurement FAQ
Q1: Is this product suitable for clinical use?A: No. This is a research-grade reagent. Shaanxi Sunrise strictly prohibits its use in human/animal clinical applications or commercial drug production.
Q2: How do you ensure the stability of Eptifibatide Acetate?A: We utilize vacuum freeze-drying technology and recommend storage at -20°C. We provide data on stability under specific storage conditions with each batch.
Q3: Do you support university and R&D lab orders?A: Yes, we supply to legal research institutions and pharmaceutical R&D labs globally. Verification of business/institutional credentials is required.